Influence
April 24, 2025

Supply, demand, and a growing US kidney transplant waiting list

Rachel Patzer, PhD

Published in JAMA Network Open. Here is a link to the article. 

Regenstrief Institute author: Rachel Patzer, PhD, MPH 

Expanding access to the kidney transplant waiting list for nearly 800,000 individuals with end-stage kidney disease (ESKD) remains a central policy focus in the United States. Currently, only one in eight ESKD patients are added to the waiting list, and longstanding disparities—whether geographic, racial, ethnic, or economic—continue to challenge efforts to ensure fair access to transplantation. Regulatory initiatives, including those by the Centers for Medicare and Medicaid Services, now tie transplant access to financial incentives for dialysis and transplant centers, aiming to promote greater impartiality in access. 

At the center level, increasing and maintaining a transplant waiting list requires significant personnel and resources. On a national scale, these efforts must align with strategies to expand the organ donor pool. In 2023, 44,560 patients were added to the waiting list, yet only 27,332 transplants occurred. Although list additions have risen, the percentage of ESKD patients gaining access has declined—from 17.7% in 2013 to 12.3% in 2021. In many areas, wait times exceed three years, sometimes reaching a decade. 

Caldwell et al. employed a Markov model to estimate the effect of waiting list growth on transplant delays. A 10% list expansion could extend median wait times by four months; a 50% increase could add 20 months. Doubling deceased-donor or tripling living-donor volume would be needed to offset these delays. While challenges in modeling exist, these projections help policymakers plan. To ensure fairness in access, efforts must simultaneously improve waiting list entry and boost both deceased and living organ donations. 

Authors 

David C. Cron, MD, MS1; Rachel E. Patzer, PhD, MPH2,3; Joel T. Adler, MD, MPH4 

Author Affiliations 

1Department of Surgery, Massachusetts General Hospital, Boston 

2Department of Surgery, Indiana University School of Medicine, Indianapolis 

3Regenstrief Institute, Indianapolis, Indiana 

4Department of Surgery and Perioperative Care, Dell Medical School, University of Texas at Austin 

Related News

Jiang Bian, PhD

Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy

Published in Journal of the American College of Cardiology (JACC) CardioOncology. Here is a link to the article.  Regenstrief

Shaun Grannis, M.D., M.S.

Study reveals gaps in flu treatment for high-risk adults

INDIANAPOLIS – A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent

Michael Weiner, MD, MPH

Regenstrief Institute researcher departs after more than two decades of service 

After more than two decades of impactful work in Indiana, Michael Weiner, M.D., MPH, is departing Regenstrief Institute, Indiana

Regenstrief researcher honored by awards from Indiana University and Ball State University

Regenstrief Institute Research Scientist William Tierney, M.D., renowned for his groundbreaking work in health informatics, population health and global